JOURNEY OF A DRUG: FROM DISCOVERY TO REGULATORY APPROVAL: A COMPREHENSIVE REVIEW
DOI: 
SHARE THIS ARTICLE
DOWNLOAD ARTICLE
REVIEW REPORT
CITE THIS ARTICLE
Drug discovery and development is a complex, multidisciplinary process that integrates pharmacology, medicinal chemistry, toxicology, bioinformatics, regulatory science, and clinical research to identify, optimize, and evaluate therapeutic agents. The traditional drug development pipeline is lengthy, costly, and associated with high attrition rates. However, significant advancements between 2020 and 2026 have transformed the pharmaceutical landscape through the adoption of artificial intelligence (AI), machine learning, high-throughput screening, computational modeling, and systems biology approaches. These technologies have enhanced target identification, lead optimization, and prediction of drug efficacy and safety, thereby improving the efficiency of drug development.
Recent innovations in precision medicine, genomics, biomarker-driven therapies, and adaptive clinical trial designs have further accelerated the translation of scientific discoveries into clinical applications. Additionally, emerging modalities such as RNA-based therapeutics, gene editing technologies, and advanced drug delivery systems have expanded treatment possibilities for complex diseases. This review provides a comprehensive overview of contemporary trends, technological advancements, regulatory considerations, and future perspectives in drug discovery and development from 2020 to 2026, highlighting their impact on improving therapeutic outcomes and reducing development timelines.
Keywords
Article Information
Article Metrics
HOW TO CITE
Copy
Shil, D. (2026). Journey of a Drug: From Discovery to Regulatory Approval: A Comprehensive Review. International Journal of Science, Strategic Management and Technology, 02(6). https://doi.org/10.55041/ijsmt.v2i6.113
Shil, Dipayan. "Journey of a Drug: From Discovery to Regulatory Approval: A Comprehensive Review." International Journal of Science, Strategic Management and Technology, vol. 02, no. 6, 2026, pp. . doi:https://doi.org/10.55041/ijsmt.v2i6.113.
Shil, Dipayan. "Journey of a Drug: From Discovery to Regulatory Approval: A Comprehensive Review." International Journal of Science, Strategic Management and Technology 02, no. 6 (2026). https://doi.org/https://doi.org/10.55041/ijsmt.v2i6.113.
References
2.Blanco-González, A., Cabezon, A., Seco-González, A., & Revuelta, J. L. (2023). The role of artificial intelligence in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals, 16(6), 891. https://doi.org/10.3390/ph16060891
3.Serrano, D. R., Lalatsa, A., Dea-Ayuela, M. A., Bilbao-Ramos, P., Garrett, N. L., Moger, J., & Guarrochena, X. (2024). Artificial intelligence applications in drug discovery and development. Pharmaceutics, 16(10), 1265. https://doi.org/10.3390/pharmaceutics16101265
4.Zhang, K., Xiao, C., Glass, L. M., & Sun, J. (2025). Artificial intelligence in drug development. Nature Medicine, 31, 1–15. https://doi.org/10.1038/s41591-024-03434-4
5.Ferreira, F. J. N., et al. (2025). AI-driven drug discovery: A comprehensive review. ACS Omega, 10(24), 26388–26420. https://doi.org/10.1021/acsomega.5c00549
6.Hasselgren, C., & Oprea, T. I. (2023). Artificial intelligence for drug discovery: Are we there yet? Annual Review of Pharmacology and Toxicology, 64, 211–230. https://doi.org/10.1146/annurev-pharmtox-051422-114510
7.Deng, J., Yang, Z., Ojima, I., Samaras, D., & Wang, F. (2021). Artificial intelligence in drug discovery: Applications and techniques. Briefings in Bioinformatics, 22(6), bbab430. https://doi.org/10.1093/bib/bbab430
8.Sun, D., Gao, W., Hu, H., & Zhou, S. (2022). Why 90% of clinical drug development fails and how to improve it. Acta Pharmaceutica Sinica B, 12(7), 3049–3062. https://doi.org/10.1016/j.apsb.2022.02.002
9.Yamaguchi, S., Kaneko, M., & Narukawa, M. (2021). Approval success rates of drug candidates based on target, action, modality, and application. Clinical and Translational Science, 14(3), 1113–1122. https://doi.org/10.1111/cts.12980
10.Kim, E., Lee, S., & Kim, H. (2023). Factors affecting success of new drug clinical trials. Healthcare, 11(9), 1297. https://doi.org/10.3390/healthcare11091297
Ethics and Compliance
Indexed In
Similar Articles
Previous Article
